T Pallidum Hemagglutination

The T. Pallidum Haemagglutination Assay (TPHA) is a blood test used to detect antibodies produced by the body in response to Treponema pallidum, the bacterium responsible for syphilis. Syphilis is a sexually transmitted infection that progresses through distinct stages. It can cause serious complications if left untreated, including damage to the heart, brain, and nervous system. This test works by detecting specific antibodies that the immune system produces against the bacterium, making it a highly specific confirmatory test for syphilis. Unlike non-treponemal screening tests, the TPHA directly targets antibodies against T. pallidum antigens, which means it is less likely to produce false positive results. This test is widely used to confirm a syphilis diagnosis, especially when a screening test such as VDRL or RPR has come back reactive. It is also useful in detecting past syphilis infection, as these antibodies can remain in the blood for years even after successful treatment.

 Who Should Get This Test Done?

This test is recommended for individuals who:

•      Have had unprotected sexual contact with a new or multiple partners

•      Notice a painless sore or ulcer on the genitals, mouth, or rectum

•      Have a skin rash on the palms of the hands or soles of the feet

•      Experience unexplained fever, swollen lymph nodes, or fatigue

•      Are pregnant, as syphilis can be transmitted to the unborn baby and cause serious complications

Why Consider This Test?

The TPHA test is an important confirmatory test for syphilis, especially when an initial screening test shows a positive result. Because it is highly specific, it helps confirm the diagnosis and reduces the risk of false-positive results that can occur with some screening tests. Accurate diagnosis allows treatment to begin early, when syphilis can be effectively cured with antibiotics. Without timely detection and treatment, the infection may progress silently and eventually cause serious complications affecting the heart, brain, and nervous system. In pregnant women, early diagnosis is particularly important because untreated syphilis can be passed to the baby, leading to miscarriage, stillbirth, birth defects, or severe illness in the newborn. The TPHA test can also help determine whether a person has been infected with syphilis in the past and support clinical evaluation alongside other tests and medical history.

More Information

The TPHA test requires a small blood sample drawn from a vein, and no special preparation or fasting is typically required beforehand. A positive result indicates the presence of treponemal antibodies and is usually interpreted alongside the clinical history and other syphilis tests such as VDRL, RPR, or FTA-ABS for a complete picture. It is important to note that the TPHA can remain positive for life even after successful treatment, so a positive result alone does not necessarily indicate active infection. Results are reported as reactive or non-reactive, and in some cases, a titre may be provided to assess the level of antibody activity. A doctor’s guidance is essential for accurate interpretation and appropriate follow-up care.

 Other Names

•      TPHA test

•      Treponema pallidum haemagglutination assay

•      Syphilis confirmatory test

•      Treponemal antibody test

•      TPHA syphilis test